FIELD: biochemistry.
SUBSTANCE: invention relates to dipeptide mimetic selected from glutaminyl thiazolidine or glutaminyl pyrrolodine and salts thereof as well as to using of such compounds in treatment of abnormal glucose tolerance, glucoseuria, diabetes mellitus and other disordered as well as complications associated with diabetes mellitus in mammalians.
EFFECT: new effectors of dipeptidyl peptidase IV.
18 cl, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW EFFECTORS OF DIPEPTIDYLPEPTIDASE IV | 1999 |
|
RU2227800C2 |
| NEW DIPEPTIDYL PEPTIDASE IV INHIBITORS AND USES THEREOF AS HYPOTENSIVE AGENT | 2002 |
|
RU2305553C2 |
| COMPOUNDS OF UNSTABLE INHIBITORS OF DIPEPTIDYLPEPTIDASE IV | 1999 |
|
RU2226195C2 |
| USE OF EFFECTORS DECREASING ACTIVITY OF DIPEPTIDYL-PEPTIDASE (DP IV) AND ENZYME DP IV RESPECTIVELY WITH SIMILAR ACTIVITY FOR DECREASE OF BLOOD GLUCOSE LEVEL | 1997 |
|
RU2189233C2 |
| NOVEL INHIBITORS OF DIPEPTIDYL PEPTIDASE IV AND THEIR USING AS ANTICANCER AGENTS | 2002 |
|
RU2299066C2 |
| METHOD FOR IMPROVING SIGNAL TRANSFER IN ISLETS OF LANGERHANS IN DIABETES MELLITUS AND IN ITS PROPHYLAXIS | 2001 |
|
RU2261096C2 |
| PRODRUGS OF DIPEPTIDYLPEPTIDASE IV INHIBITORS | 1999 |
|
RU2226533C2 |
| DIPEPTIDYL PEPTIDASE IV INHIBITING AGENT AND PHARMACEUTICAL COMPOSITION THEREOF | 2011 |
|
RU2485952C2 |
| APPLICATION OF DPP-IV INHIBITOR FOR REDUCTION OF GLYCEMIA ACUTE EXACERBATION | 2006 |
|
RU2440143C2 |
| DPP-IV INHIBITOR CONTAINING BETA AMINO GROUP, METHOD FOR MAKING THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING IT FOR PREVENTION AND TREATMENT OF DIABETES OR OBESITY | 2008 |
|
RU2419615C1 |
